ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,116.17
0.32%
US Tech 100
17,282.40
-0.16%
다우존스 지수
38,386.09
0.38%
Bitcoin
61,678.59
-3.38%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Alvontech (ALVO)

  7. Alvontech (ALVO) 뉴스

ALVO Alvontech

14.22
0.00 (0.00%)
시간외 단일가
최종 업데이트: 18:44:07
15분 지연
기업명 주식 심볼 시장 주식 타입
Alvontech ALVO 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 14.22 18:44:07
개장가 저가 고가 종가 전일 종가
14.22
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
30/04/202417:00GLOBEU.S. Commercialization Agreement with Quallent to Drive..
24/04/202417:00GLOBEAlvotech Announces Topline Results from a Confirmatory..
19/04/202419:10GLOBEAlvotech signs U.S. agreement to expand access for newly..
17/04/202406:43BWAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
17/04/202406:30GLOBEAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
03/04/202420:41GLOBEAlvotech Hosts Audio Call for Investors at 8:15 am EDT on..
23/03/202405:15GLOBEAlvotech Announces Increase in Number of Own Shares
21/03/202405:15GLOBEAlvotech Reports Financial Results for Full Year 2023 and..
20/03/202420:17IHMARKETNEWSU.S. Index Futures Trade Sideways Amid Anticipation of Fed’s..
06/03/202406:00GLOBEAlvotech Announces Webcast of Full Year 2023 Financial..
01/03/202406:05GLOBEAlvotech Appoints Interim Chief Quality Officer
26/02/202418:25GLOBEAlvotech Accepts Offer for the Sale of Shares for a value of..
24/02/202410:15GLOBEAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
24/02/202410:15BWAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
15/02/202420:30GLOBEAlvotech Announces Expected Global Market Entry Dates for..
29/01/202418:00GLOBEAlvotech Announces Positive Top-Line Results from a..
20/01/202402:31DJNAlvotech Shares Climb After FDA Concludes Facility..
20/01/202401:30GLOBEAlvotech Provides Update on Status of Biologics License..
10/01/202417:30GLOBESTADA and Alvotech secure approval for Uzpruvo, Europe’s..
03/01/202417:30GLOBEAlvotech Clinical Study Results Demonstrate Therapeutic..
29/11/202318:00GLOBEAlvotech Announces Positive Top-Line Results from a..
29/11/202306:15GLOBEAlvotech Reports Financial Results for First Nine Months of..
21/11/202322:00GLOBEAlvotech to Report Financial Results for the First Nine..
14/11/202321:00GLOBEAlvotech and JAMP Pharma Announce Receipt of Marketing..
10/11/202323:30GLOBESTADA and Alvotech receive positive CHMP opinion for..
07/11/202322:00GLOBEAlvotech to Present at the Jefferies 2023 London Healthcare..
12/10/202317:00GLOBEAlvotech Provides Update on Status of U.S. Biologics License..
03/10/202321:29BWKashiv BioSciences Enters into Exclusive Licensing Agreement..
03/10/202318:00GLOBEAlvotech Enters into Exclusive Licensing Agreement with..
25/09/202317:00GLOBEAlvotech Announces Approval in Japan of AVT04 (ustekinumab),..
20/09/202317:30GLOBEAlvotech Provides U.S. Regulatory Update on AVT02, a..
05/09/202322:30GLOBEAlvotech Announces Changes to the Leadership Team
31/08/202305:15GLOBEAlvotech Reports Financial Results for First Six Months of..
29/08/202318:00GLOBEAlvotech and Bioventure Announce Approval of AVT02..
22/08/202322:15GLOBEAlvotech to Report Financial Results for the First Half of..
31/07/202317:00GLOBEAlvotech Completes $100 Million Convertible Bond Private..
24/07/202317:00GLOBETeva Pharmaceuticals and Alvotech Provide Update on..
03/07/202322:37DJNAlvotech Shares Rebound 20% After FDA Letter Selloff
29/06/202309:03DJNAlvotech Gets FDA Letter, Expects Delay in U.S. Approval of..
29/06/202308:00GLOBEAlvotech Provides Regulatory Update on Second Biologics..
12/06/202320:00BWAlvotech and Teva Secure U.S. License Date for AVT04, a..
12/06/202316:00GLOBEAlvotech and Teva Secure U.S. License Date for AVT04, a..
31/05/202318:20GLOBEAlvotech to Participate in Jefferies Healthcare Conference
24/05/202318:00GLOBEAlvotech and Advanz Pharma extend strategic partnership to..
19/05/202318:00GLOBEAlvotech Reports Financial Results for First three Months of..
17/05/202318:00GLOBEAlvotech to Participate in Morgan Stanley Annual..
15/05/202318:00GLOBEAlvotech Issues Annual Equality Report Covering 2022
10/05/202318:00GLOBEAlvotech enters into commercialization agreement with..
04/05/202318:00GLOBEAlvotech Initiates Confirmatory Patient Study for AVT05, a..
03/05/202322:00GLOBEAlvotech to Report First Quarter 2023 Financial Results and..

최근 히스토리

NASDAQ
ALVO
Alvontech
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유